Results 141 to 150 of about 63,958 (182)

Lower serum GPX4 and GSH/GSSG ratio are associated with poor prognosis in severe community-acquired pneumonia. [PDF]

Eur J Med Res
Zhu W, Wang K, Xing X, Xu X, Liang Y, Wang K.   +5 more
europepmc   +1 more source

Corticosteroids for the management of severe community-acquired pneumonia: A UK-wide survey. [PDF]

J Intensive Care Soc
Terrington I, Cox O, Webb E, Eastwood B, Copley P, Saeed K, Conway Morris A, Grocott MP, Dushianthan A.   +8 more
europepmc   +1 more source

The role of bronchoalveolar lavage fluid metagenomic next-generation sequencing in detecting pathogens and optimising antibiotic therapy in paediatric severe community-acquired pneumonia. [PDF]

Front Cell Infect Microbiol
Xu Y, Ma Y, Huang Q, Guo X, Guo L, Ren Y, Lu W, Wu X, Li D, Li S.   +9 more
europepmc   +1 more source

Hydrocortisone in Severe Community-Acquired Pneumonia [PDF]

New England Journal of Medicine, 2023
info:eu-repo/semantics ...
Julio Badie, Jean Reignier, Jean-Pierre FRAT   +2 more
exaly   +10 more sources

Severe community-acquired pneumonia [PDF]

Current Opinion in Pulmonary Medicine, 1996
Community-acquired pneumonia is an important public health concern and a recent focus of clinical practice guidelines. What has become clear from this renewed focus of attention is that a subgroup of patients with community-acquired pneumonia have severe disease with a differing spectrum of pathogens and prognosis.
H A, Cassiere, A M, Fein
openaire   +3 more sources